Enveric Biosciences, Inc. (ENVB) Dividend History

Enveric Biosciences, Inc. (ENVB) is a biotechnology company focused on developing innovative medicines derived from psychedelic and plant-based compounds. The company aims to create therapies for mental health and neurological conditions by utilizing psychedelic science and advanced drug development techniques.

4851 Tamiami Trail N, Suite 200, Naples, FL, 34103
Phone: 239-302-1707
Website: https://www.enveric.com

Dividend History

Enveric Biosciences, Inc. currently does not pay dividends

Company News

Enveric Biosciences, Inc. (ENVB) Stock Falls Amid Market Uptick: What Investors Need to Know

The latest trading day saw Enveric Biosciences, Inc. (ENVB) settling at $0.93, representing a -0.46% change from its previous close.

Zacks Investment Research
Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors

Enveric Biosciences, Inc. (ENVB) closed the most recent trading day at $0.90, moving -0.56% from the previous trading session.

Zacks Investment Research
New Strong Buy Stocks for April 17th

BYRN, YMAB, SAND, CORT and ENVB have been added to the Zacks Rank #1 (Strong Buy) List on April 17, 2023.

Zacks Investment Research

Featured Companies: BYRN CORT SAND YMAB
What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock

Enveric Biosciences (ENVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research
New Strong Buy Stocks for April 12th

ZUO, INTZ, SIGA, ENVB and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on April 12, 2024.

Zacks Investment Research

Featured Companies: INTZ NTRS SIGA

Dividend data last updated 06/07/2025 14:30:31 UTC